Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-05

FDA Approved: NEBIVOLOL — Supplemental Application (Modavar Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Modavar Pharmaceuticals LLC's supplemental application for Nebivolol, updating the approval status of an existing Nebivolol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

SUPPL AP for NEBIVOLOL (NEBIVOLOL)